PRESS RELEASE published on 07/08/2024 at 16:30, 2 years 1 month ago Issuance of New European & Australian Patents Bolster IP Protection for Jaguar Health in the Treatment of Short Bowel Syndrome (SBS) and Congenital Diarrheal Disorders (CDDs) New patents issued for core rare disease target indications for crofelemer. Jaguar Health announces new patents from European Patent Office and IP Australia for Napo Pharmaceuticals' crofelemer. Expected results in 2024 and 2025 Napo Pharmaceuticals Crofelemer Jaguar Health Patents Rare Disease
Published on 08/29/2026 at 05:15, 1 day 9 hours ago Norsemont Announces Restatement of Financial Statements
Published on 08/29/2026 at 03:20, 1 day 11 hours ago BEACN Announces Financial Results for the Second Quarter of 2026
Published on 08/29/2026 at 01:15, 1 day 13 hours ago Gamma Resources Announces Increase in Private Placement to $1,750,000 and Closing of First Tranche at $872,500
Published on 08/29/2026 at 01:00, 1 day 13 hours ago Lobe Sciences Ltd. Announces Upsize to Non-Brokered Private Placement
Published on 08/28/2026 at 23:00, 1 day 15 hours ago Guanajuato Silver Grants Stock Options to Officer
Published on 08/29/2026 at 04:05, 1 day 10 hours ago INTCO Medical Reports 40.6% H1 2026 Revenue Growth, Expands World's Largest Disposable Glove Capacity to 107 Billion Pieces
Published on 08/28/2026 at 20:49, 1 day 18 hours ago Publication pursuant to Article 5(1)(b) and (3) of Regulation (EU) No. 596/2014 and Article 2(2) and (3) of the Commission Delegated Regulation (EU) No. 2016/1052 - Final Announcement
Published on 08/28/2026 at 20:42, 1 day 18 hours ago Aroundtown SA: Release of a capital market information
Published on 08/28/2026 at 19:10, 1 day 19 hours ago Invitation to Professional or Qualified Investors holding Notes to submit offers for Branicks Bridge Notes and VIB Bridge Notes
Published on 08/28/2026 at 18:01, 1 day 20 hours ago CPI Europe announces unaudited results for the first half of 2026
